Investor

Salem Partners

Last cheque observed May 2026; 6 cheques on record.

Email

Growth equityDeploying nowLast fund $71K, Oct 2019

Series AGrowthSeries B

Deploying now
100%of best year1cheques in 12 months, 6 on record
Since the last cheque164days00hrs00min00sec
Median round$35MRounds led0 of 6Sole investor2 roundsExits1 from the portfolioMostly inUnited States, 100%
Pitch Salem Partners

Salem Partners highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series A and Growth: 50% of its rounds

  3. 03

    Sole investor in 2 rounds, median $24M

  4. 04

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2026

    1 round

  2. May
    RightslineGrowth · US · Ventureburn$500MWith 2 others
  3. 2019

    1 round

  4. Jul
    OncoNanoSeries A · US · FinSMEs$35MSole investor
  5. 2018

    1 round

  6. May
    OncoNanoSeries A · US · FinSMEs$12MSole investor
  7. 2015

    1 round

  8. Apr
    FemasysSeries B · US$10MWith 2 others
  9. 2014

    1 round

  10. Mar
    ZS PharmaSeries D · US$55MWith 8 others
  11. 2012

    1 round

  12. Oct
    ZS PharmaSeries C · US · bizjournals.com$46MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

SPStephen ProughMANAGERiFiling they signed

We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

ZS PharmaBought by AstraZeneca$2.7BNov 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Salem Partners. A count of rooms they were both in, not a relationship either has claimed.

3x5 Special Opportunity FundVC firm2rounds togetherAlta PartnersVC firm2rounds togetherDevon Park BioVenturesGrowth equity2rounds togetherRiverVestVC firm2rounds together

Recently backed

The latest companies Salem Partners put money into.

Rightsline$500M · May 2026

Quick answers about Salem Partners

What does Salem Partners invest in?

Salem Partners invests most often at Series A and Growth (50% of the rounds on record).

How active is Salem Partners?

6 investments on record, 1 of them in the last 12 months. The most recent was in May 2026.

What has Salem Partners invested in recently?

Its most recent investments on record: Rightsline (Growth, May 2026) and OncoNano (Series A, Jul 2019).

How big are Salem Partners's cheques?

The median round it joins is $35M.

Does Salem Partners lead rounds?

Rarely, if at all: none of its 6 investments on record names it as the lead.

Where does Salem Partners invest?

Most of the companies it backs are in the United States (100%).

Is Salem Partners investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Salem Partners invest alongside?

Most often 3x5 Special Opportunity Fund (2 rounds together), Alta Partners (2 rounds together) and Devon Park BioVentures (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it